Suppr超能文献

散瞳后房水闪光和细胞的变化。

Changes in aqueous flare and cells after mydriasis.

作者信息

Oshika T, Kato S

机构信息

Department of Ophthalmology, Tokyo Kosei Nenkin Hospital, Japan.

出版信息

Jpn J Ophthalmol. 1989;33(3):271-8.

PMID:2796008
Abstract

The influence of a commonly used short-acting mydriatic agent, tropicamide-phenylephrine, on aqueous flare intensity and cell number was studied both in postsurgical cases and normal subjects. Measurements with a laser flare-cell meter were carried out in 40 patients who had undergone planned extracapsular cataract extraction with posterior chamber intraocular lens implantation. On the second postoperative day, 20 patients received one drop of a combined solution of 0.5% tropicamide and 0.5% phenylephrine, and the remaining patients received no mydriatic agents. Flare-cell meter measurements in the non-mydriasis group were rather difficult, and measurements in 12 out of 20 (60%) cases were discontinued. In the mydriasis group, flare intensity became significantly lower 2 hours after the application (P less than 0.01) and continued to decrease throughout the rest of the measurement period. The cell counts tended to decrease throughout the period after mydriasis and showed significantly lower values compared to the initial value (P less than 0.01). It was considered that measurements with this instrument in postoperative cases are best performed between 30 minutes to 1 hour after the application of the short-acting mydriatic agents. In normal human eyes, the effects of 0.5% phenylephrine-0.5% tropicamide, 0.4% tropicamide, and 5% phenylephrine on aqueous flare and cells were tested separately. Aqueous flare intensity was significantly decreased by tropicamide-phenylephrine at 1, 1.5 and 2 hours (P less than 0.05), by tropicamide at 1 and 1.5 hours (P less than 0.01), and by phenylephrine at 3 hours (P less than 0.01) after the application, respectively. Values returned to normal following these transient decreases.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

研究了常用短效散瞳剂托吡卡胺 - 去氧肾上腺素对手术患者和正常受试者房水闪光强度及细胞数量的影响。对40例行计划性囊外白内障摘除联合后房型人工晶状体植入术的患者,使用激光闪光细胞仪进行测量。术后第二天,20例患者滴入一滴0.5%托吡卡胺和0.5%去氧肾上腺素的混合溶液,其余患者未使用散瞳剂。未散瞳组的闪光细胞仪测量相当困难,20例中有12例(60%)测量中断。散瞳组在用药后2小时闪光强度显著降低(P<0.01),并在整个测量期的其余时间持续下降。散瞳后细胞计数在整个期间呈下降趋势,与初始值相比显著降低(P<0.01)。认为在术后病例中,使用该仪器测量最好在使用短效散瞳剂后30分钟至1小时之间进行。在正常眼中,分别测试了0.5%去氧肾上腺素 - 0.5%托吡卡胺、0.4%托吡卡胺和5%去氧肾上腺素对房水闪光和细胞的影响。用药后1、1.5和2小时,托吡卡胺 - 去氧肾上腺素使房水闪光强度显著降低(P<0.05);1和1.5小时,托吡卡胺使其显著降低(P<0.01);3小时,去氧肾上腺素使其显著降低(P<0.01)。这些短暂降低后数值恢复正常。(摘要截选至250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验